Becca Senter

Company: Axial Therapeutics, Inc.

Job title: Vice President, Head of Preclinical R&D

Seminars:

Development of AX-5006, a Small Molecule Inhibitor of CsgA Aggregation as a Symptomatic & Disease-Modifying Treatment for Parkinson’s Disease 1:45 pm

Understanding the role of the microbiome in Parkinson’s Disease Outlining the rationale for targeting CsgA as a therapeutic for Parkinson’s Disease Revealing the preclinical efficacy and development profile of AX-5006Read more

day: Day Two Track A (PM)

Panel Discussion: Defining Innovative Clinical Strategies Conserving Spend 9:00 am

Join panelists to address securing funding strategies and perspectives on: What adaptive trial methodologies or other innovative approaches can biopharma look to incorporate for cost-efficiency which also guarantee rigor? What are the benefits and drawbacks of strategic partnerships as an approach to expertise sharing and accelerated progress in microbiome drug development? What criteria and benchmarks…Read more

day: Conference Day Two